A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group

D. H. Johnson, L. H. Einhorn, R. Birch, R. Vollmer, C. Perez, S. Krauss, G. Omura, F. A. Greco